Spotify removed thousands of podcasts promoting online prescription drug sales, investigation finds

Spotify Removes Thousands of Podcasts Promoting Prescription Drug Sales

Investigation Unveils Spotify’s Action Against Fraudulent Content

Spotify removed thousands of podcasts promoting – A recent investigation has revealed that Spotify removed thousands of podcasts that promoted online prescription drug sales. The findings, shared by the Joint Economic Committee, indicate that the music streaming platform took down over 100,000 suspicious podcasts last year, many of which linked to unregulated pharmacies. The report, released on Thursday, underscores Spotify’s efforts to combat counterfeit drugs sold through its platform. This development follows earlier media reports in May 2025, which exposed the issue. At that time, Spotify confirmed removing dozens of podcasts associated with pharmacies distributing medications like Adderall and Oxycontin without proper prescriptions.

Delayed Responses and Transparency Concerns

The investigation, led by Senator Maggie Hassan of New Hampshire, highlighted delays in Spotify’s response to the issue. Hassan, a Democrat, pointed out that the company acted too slowly in addressing the proliferation of illegal content. “As AI tools enable scammers to expand their reach, platforms must act decisively to protect users,” she said in a statement provided to CNN. The report showed Spotify’s removal process was reactive, with 3,500 podcast accounts and 57,000 episodes taken down by November 2025, compared to fewer than 100 accounts removed in the prior year. Spotify acknowledged that its data tracking methods were “less comprehensive for earlier years,” but the senator criticized the lag in action as a risk to public health.

“The online landscape is changing fast, and platforms need to evolve,” Hassan added. The findings also raised concerns about Spotify not alerting law enforcement to the podcasts it removed, despite their potential to harm listeners. Critics, including parents and healthcare experts, argue that the unchecked spread of counterfeit drugs through podcasts has contributed to overdoses among young people, with multiple teens losing their lives to pills purchased online.

Spotify’s Explanation for the Removals

Spotify defended its decision by framing the removals as part of a “spam attack” designed to boost the visibility of online pharmacies. According to the report, the company’s spokesperson, Laura Batey, stated that the content was not explicitly targeting Spotify users for drug sales. “Bad actors will always find ways to circumvent our detection systems,” Batey told CNN. “But once we identified their tactics, we acted swiftly to remove the material and improve our monitoring tools.”

The platform’s guidelines prohibit content that “illicitly promotes the sale of regulated or illegal goods,” such as narcotics. Spotify employs a combination of automated systems and human review to enforce these rules. However, the investigation found that none of the removed podcasts were monetized, supporting Spotify’s claim that they generated no revenue. Despite this, the company noted that some podcasts had gained significant traction, including two with nearly 13,000 streams that directed users to purchase modafinil using bitcoin.

Podcast Engagement and User Impact

Spotify provided detailed data to investigators, revealing that 94% of the removed podcasts had never been streamed. The platform defines a single stream as a listening session lasting over 30 seconds. While most of the content was obscure, a small fraction reached a broader audience. The report highlighted the two high-engagement podcasts linked to modafinil sales as exceptions, suggesting they had targeted outreach. However, Spotify insists these were part of a larger spam campaign, not a deliberate strategy to exploit users.

Lawmakers and experts have called for stricter oversight of tech companies, citing the lack of tracking for user interactions with embedded hyperlinks in podcasts. Spotify admitted it “does not track interaction with hyperlinks,” making it challenging to assess how many listeners may have been directed to potentially illegal websites. This gap in data collection has intensified scrutiny over the platform’s role in the distribution of counterfeit medications.

Broader Implications for Digital Content Regulation

The findings prompt a broader conversation about how digital platforms regulate content. With the rise of AI-driven scams, Spotify’s response to fraudulent podcasts serves as a case study for other companies. The report’s release highlights the need for more proactive measures to prevent harmful content from reaching users. As the music streaming giant continues to refine its policies, the debate over accountability in the digital space is expected to grow. Parents and health advocates remain concerned about the influence of these podcasts on young audiences, urging Spotify to enhance its monitoring capabilities.